Koshinski Asset Management, Inc. Oncocyte Corp Transaction History

Koshinski Asset Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$0.86 - $1.53 $1,892 - $3,366	-2,200 Closed	0 $0
Q4 2021 Jan 14, 2022	SELL	$2.04 - $3.59 $2,040 - $3,590	-1,000 Reduced 31.25%	2,200 $4.77 Million
Q3 2021 Oct 12, 2021	BUY	$3.53 - $5.89 $11,296 - $18,848	3,200 New	3,200 $11,000

411K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $260M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Koshinski Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Koshinski Asset Management, Inc. with notifications on news.